I'm really interested in why we're repeating at th
Post# of 148173
For me, (i) hearing the enrollment is going great in Brazil, and (ii) hearing something about revenue / activity in Phillipines, and / or (iii) we have hired a new CRO, and they are awesome - and the BLA is clicking along - would be plenty. Anything else like cancer and NASH would be gravy.
I say that because i view COVID (including LH) and HIV as our near-term revenue streams (next 12 months) and everything else as further out. maybe i'm wrong about that, and we get BTD (which would be great) but i'd like to knock this low hanging fruit off the branch first! - and then the world is at our feet!